Search results

The SAAFE Program supports early career researchers at PhD and Postdoctoral level to expand research and innovation activities within Human Health, the Environment and the Nuclear Fuel Cycle, to initiate sustainable research networks and linkages to support Australia, New Zealand and France research and innovation.

ANSTO will make an application to the independent nuclear regulator, ARPANSA, to vary its license for its Interim Waste Store. The original operating license was approved in 2015, enabling the facility to hold what is called a TN-81 cask of intermediate-level radioactive waste that was safely repatriated from France in 2015.

A world-first processing technology developed in collaboration by ANSTO’s Minerals unit.

See details of previously published customer updates from our Health products team. 

Using nuclear techniques to help sustain Australia's finite groundwater resources

The Medium Energy- X-ray Absorption Spectroscopy beamlines provides access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.

A large group of ANSTO environmental scientists and collaborators have produced the first groundwater stable isotopes, ‘isoscapes’, intuitive maps with grid data, across NSW combining new and pre-existing isotope measurements.

Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.

ANSTO shared expertise on next-generation reactors and nuclear power with sustainable energy experts at the Australian Academy of Science symposium in May.

ANSTO scientist, Dr Klaus Wilcken of the Centre for Accelerator Science, used cosmogenic nuclide dating to determine the ages of layered sand and gravel samples, in which seven footprints of the flightless bird, the moa, were found on the South Island in New Zealand in 2019.

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.